Investing Profile

Ansbert Gadicke

VCInvestor
Managing Director at MPM Capital
mpmcapital.com/team/Boston, Massachusetts
Photo of Ansbert Gadicke, Managing Director at MPM Capital

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
MPM Capital Managing Director
$1M - $150.0M
$25.0M
25
$100M
CompanyStageDateRound SizeTotal Raised
Reunion Neuroscience
Series AMay 2024$100M
$100M
ElevateBio
Series DMay 2023$400M
$930M
Co-investors: Deep Nishar (General Catalyst)
ReNAgade Therapeutics
Series AMay 2023$300M
$300M
Orna Therapeutics
Series BAug 2022$220M
Series AFeb 2021$80M
SeedJan 2020$20M
$320M
Co-investors: Sakae Asanuma (Taiho Ventures), Shinichiro Fuse
ITeos Therapeutics
Series BJun 2018$75M
$200M
Co-investors: Derek DiRocco (RA Capital)
TCR2
Series BMar 2018$130M
Series ADec 2016$45M
$170M
Co-investors: Patrick Baeuerle (MPM Capital), Wei Li (Creacion Ventures)
Chiasma
Series EFeb 2015$70M
Series DJul 2012$39M
Series CNov 2006$44M
$160M
Co-investors: Bard Geesaman (MPM Capital), Vincent Miles (Abingworth), Scott Minick (ARCH Venture Partners), Todd Foley (MPM Capital)
Raze Therapeutics
Series AOct 2014$24M
$24M
Co-investors: Hakan Goker (M Ventures (Merck)), Jason Rhodes (Atlas Venture), Peter Barrett (Atlas Venture), Reza Halse (RA Capital)